Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Electrocardiography | 108 | 2023 | 6441 | 9.400 |
Why?
|
Electrocardiography, Ambulatory | 42 | 2023 | 585 | 8.630 |
Why?
|
Arrhythmias, Cardiac | 76 | 2023 | 2267 | 7.770 |
Why?
|
Heart Rate | 91 | 2023 | 4091 | 7.520 |
Why?
|
Heart Conduction System | 42 | 2021 | 1047 | 6.010 |
Why?
|
Ventricular Fibrillation | 74 | 2023 | 538 | 5.950 |
Why?
|
Flecainide | 8 | 2021 | 42 | 5.330 |
Why?
|
Anti-Arrhythmia Agents | 19 | 2023 | 788 | 5.150 |
Why?
|
Vagus Nerve Stimulation | 10 | 2022 | 200 | 4.970 |
Why?
|
Death, Sudden, Cardiac | 38 | 2023 | 1542 | 4.460 |
Why?
|
Atrial Fibrillation | 27 | 2023 | 5033 | 4.040 |
Why?
|
Long QT Syndrome | 11 | 2022 | 453 | 3.550 |
Why?
|
Autonomic Nervous System | 26 | 2021 | 671 | 3.470 |
Why?
|
Tachycardia, Ventricular | 19 | 2023 | 1272 | 3.250 |
Why?
|
Acetanilides | 9 | 2014 | 168 | 2.940 |
Why?
|
Epilepsy | 11 | 2023 | 3284 | 2.490 |
Why?
|
Oxazepines | 4 | 2017 | 18 | 2.280 |
Why?
|
Exercise Test | 21 | 2019 | 2074 | 2.170 |
Why?
|
Sodium Channel Blockers | 6 | 2017 | 176 | 2.150 |
Why?
|
Coronary Stenosis | 7 | 2021 | 833 | 2.150 |
Why?
|
Torsades de Pointes | 5 | 2019 | 78 | 2.090 |
Why?
|
Amiodarone | 5 | 2017 | 211 | 2.060 |
Why?
|
Atrioventricular Node | 5 | 2023 | 182 | 2.020 |
Why?
|
Myocardial Ischemia | 21 | 2021 | 2150 | 1.870 |
Why?
|
Ventricular Function, Left | 14 | 2023 | 3660 | 1.800 |
Why?
|
Swine | 30 | 2021 | 5909 | 1.550 |
Why?
|
Piperazines | 9 | 2014 | 2487 | 1.540 |
Why?
|
Heart Failure | 19 | 2023 | 10896 | 1.540 |
Why?
|
Action Potentials | 12 | 2019 | 1804 | 1.500 |
Why?
|
Pericardium | 10 | 2021 | 667 | 1.470 |
Why?
|
Metoprolol | 4 | 2020 | 93 | 1.450 |
Why?
|
Heart Atria | 11 | 2023 | 1357 | 1.450 |
Why?
|
Adrenergic beta-Antagonists | 16 | 2019 | 1240 | 1.270 |
Why?
|
Ventricular Dysfunction, Left | 7 | 2023 | 2074 | 1.250 |
Why?
|
Electrophysiologic Techniques, Cardiac | 9 | 2016 | 493 | 1.210 |
Why?
|
Atrial Premature Complexes | 2 | 2018 | 17 | 1.200 |
Why?
|
Benzazepines | 6 | 2018 | 326 | 1.190 |
Why?
|
Heart | 37 | 2023 | 4460 | 1.180 |
Why?
|
Dogs | 89 | 2019 | 3911 | 1.170 |
Why?
|
Electric Countershock | 8 | 2017 | 534 | 1.150 |
Why?
|
Coronary Circulation | 23 | 2017 | 1572 | 1.130 |
Why?
|
Cardiovascular Agents | 4 | 2017 | 850 | 1.060 |
Why?
|
Triazoles | 3 | 2015 | 904 | 1.030 |
Why?
|
Epilepsies, Partial | 2 | 2022 | 435 | 1.020 |
Why?
|
Myocardial Perfusion Imaging | 2 | 2021 | 555 | 1.010 |
Why?
|
Myocardial Infarction | 23 | 2023 | 11708 | 1.000 |
Why?
|
Defibrillators, Implantable | 11 | 2021 | 1439 | 0.940 |
Why?
|
Risk Assessment | 31 | 2021 | 23327 | 0.920 |
Why?
|
Myocardial Contraction | 18 | 2018 | 1579 | 0.860 |
Why?
|
Brugada Syndrome | 5 | 2014 | 98 | 0.860 |
Why?
|
Animals | 158 | 2021 | 168660 | 0.760 |
Why?
|
Disease Models, Animal | 24 | 2021 | 18027 | 0.730 |
Why?
|
Nitroglycerin | 6 | 2011 | 325 | 0.730 |
Why?
|
Adrenergic beta-1 Receptor Antagonists | 1 | 2020 | 30 | 0.720 |
Why?
|
Heart Diseases | 7 | 2023 | 2789 | 0.720 |
Why?
|
Romano-Ward Syndrome | 1 | 2019 | 3 | 0.690 |
Why?
|
Sus scrofa | 5 | 2020 | 438 | 0.690 |
Why?
|
Stellate Ganglion | 18 | 2019 | 44 | 0.680 |
Why?
|
Pyridines | 3 | 2015 | 2827 | 0.670 |
Why?
|
Heart Ventricles | 13 | 2023 | 3817 | 0.670 |
Why?
|
Humans | 171 | 2023 | 743811 | 0.660 |
Why?
|
Cardiac Resynchronization Therapy | 2 | 2021 | 531 | 0.650 |
Why?
|
Coronary Disease | 39 | 2018 | 6078 | 0.640 |
Why?
|
Exercise Tolerance | 3 | 2019 | 768 | 0.630 |
Why?
|
Biological Clocks | 2 | 2010 | 321 | 0.630 |
Why?
|
Death, Sudden | 10 | 2022 | 302 | 0.620 |
Why?
|
Vagus Nerve | 23 | 2021 | 439 | 0.620 |
Why?
|
Vasodilation | 4 | 2011 | 944 | 0.600 |
Why?
|
Baroreflex | 3 | 2015 | 146 | 0.600 |
Why?
|
Male | 140 | 2021 | 349776 | 0.590 |
Why?
|
Administration, Inhalation | 5 | 2020 | 1105 | 0.580 |
Why?
|
Arousal | 5 | 2010 | 1160 | 0.570 |
Why?
|
Acute Coronary Syndrome | 5 | 2021 | 2337 | 0.570 |
Why?
|
Sodium Channels | 2 | 2016 | 349 | 0.560 |
Why?
|
Adrenergic Agents | 1 | 2016 | 70 | 0.550 |
Why?
|
Catecholamines | 3 | 2016 | 387 | 0.530 |
Why?
|
Sleep, REM | 7 | 2000 | 592 | 0.530 |
Why?
|
Stress, Psychological | 24 | 2013 | 4245 | 0.530 |
Why?
|
Bundle-Branch Block | 4 | 2021 | 269 | 0.530 |
Why?
|
Reading | 1 | 2019 | 554 | 0.530 |
Why?
|
Sleep Stages | 5 | 2009 | 685 | 0.520 |
Why?
|
Seizures | 4 | 2022 | 2850 | 0.510 |
Why?
|
Anger | 6 | 2001 | 401 | 0.510 |
Why?
|
Stroke Volume | 11 | 2023 | 5002 | 0.500 |
Why?
|
Ventricular Pressure | 1 | 2015 | 199 | 0.490 |
Why?
|
Air Pollutants | 11 | 2005 | 2816 | 0.470 |
Why?
|
Heart Arrest | 2 | 2020 | 1470 | 0.460 |
Why?
|
Emotions | 5 | 2010 | 2656 | 0.460 |
Why?
|
Electrophysiological Phenomena | 1 | 2015 | 314 | 0.450 |
Why?
|
Drug Delivery Systems | 3 | 2018 | 2217 | 0.450 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2015 | 258 | 0.440 |
Why?
|
Sympathetic Nervous System | 22 | 2004 | 513 | 0.430 |
Why?
|
Coronary Artery Disease | 6 | 2021 | 6485 | 0.420 |
Why?
|
Epinephrine | 9 | 2016 | 792 | 0.420 |
Why?
|
Models, Cardiovascular | 4 | 2013 | 996 | 0.420 |
Why?
|
Sleep | 9 | 2020 | 4619 | 0.420 |
Why?
|
Blood Pressure | 38 | 2015 | 8551 | 0.420 |
Why?
|
Hemodynamics | 17 | 2016 | 4197 | 0.420 |
Why?
|
Treatment Outcome | 21 | 2023 | 63042 | 0.410 |
Why?
|
Receptors, Adrenergic, alpha-1 | 1 | 2011 | 47 | 0.400 |
Why?
|
Cardiac Pacing, Artificial | 12 | 2009 | 844 | 0.390 |
Why?
|
Bradycardia | 1 | 2013 | 307 | 0.390 |
Why?
|
Female | 115 | 2023 | 380020 | 0.390 |
Why?
|
Rest | 1 | 2015 | 901 | 0.380 |
Why?
|
Infusions, Intravenous | 4 | 2018 | 2274 | 0.370 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2210 | 0.370 |
Why?
|
Diabetes Mellitus | 3 | 2017 | 5752 | 0.370 |
Why?
|
Calcium | 4 | 2017 | 5755 | 0.360 |
Why?
|
Atrial Flutter | 1 | 2012 | 263 | 0.350 |
Why?
|
Middle Aged | 49 | 2023 | 213241 | 0.350 |
Why?
|
Tachycardia, Supraventricular | 1 | 2012 | 263 | 0.350 |
Why?
|
Survival Analysis | 4 | 2013 | 10251 | 0.340 |
Why?
|
Microvessels | 1 | 2013 | 544 | 0.340 |
Why?
|
Cardiomyopathy, Dilated | 2 | 2007 | 851 | 0.340 |
Why?
|
Drug Compounding | 2 | 2020 | 241 | 0.330 |
Why?
|
Differential Threshold | 3 | 2008 | 80 | 0.330 |
Why?
|
Circadian Rhythm | 5 | 2012 | 2620 | 0.320 |
Why?
|
Cardiovascular Diseases | 16 | 2015 | 15142 | 0.320 |
Why?
|
Angina Pectoris | 2 | 2011 | 977 | 0.320 |
Why?
|
Calcium Channel Blockers | 5 | 2010 | 692 | 0.320 |
Why?
|
Catheters, Indwelling | 2 | 2007 | 427 | 0.310 |
Why?
|
Nerve Growth Factor | 2 | 2005 | 148 | 0.310 |
Why?
|
Ventricular Remodeling | 1 | 2015 | 1225 | 0.300 |
Why?
|
Brain Ischemia | 1 | 2022 | 3264 | 0.300 |
Why?
|
Time Factors | 24 | 2020 | 40038 | 0.300 |
Why?
|
Endothelium, Vascular | 2 | 2011 | 4459 | 0.300 |
Why?
|
Prognosis | 19 | 2023 | 29052 | 0.300 |
Why?
|
Exercise Therapy | 1 | 2014 | 904 | 0.300 |
Why?
|
Pericardial Effusion | 2 | 2000 | 247 | 0.290 |
Why?
|
Myocardial Reperfusion Injury | 3 | 1996 | 476 | 0.290 |
Why?
|
Electric Stimulation | 23 | 2015 | 1760 | 0.290 |
Why?
|
Population Surveillance | 2 | 2015 | 2614 | 0.290 |
Why?
|
Propanolamines | 4 | 2012 | 167 | 0.290 |
Why?
|
Foreign-Body Reaction | 1 | 2007 | 158 | 0.290 |
Why?
|
Coronary Vessels | 13 | 2011 | 3106 | 0.280 |
Why?
|
Atrioventricular Block | 3 | 2013 | 120 | 0.280 |
Why?
|
Receptors, Adrenergic, beta-3 | 1 | 2005 | 63 | 0.270 |
Why?
|
Syndrome | 2 | 2023 | 3249 | 0.260 |
Why?
|
Finland | 7 | 2018 | 602 | 0.260 |
Why?
|
Risk Factors | 29 | 2019 | 72252 | 0.260 |
Why?
|
Air Pollution | 6 | 2009 | 2286 | 0.260 |
Why?
|
Diltiazem | 3 | 2013 | 133 | 0.260 |
Why?
|
Practice Guidelines as Topic | 3 | 2012 | 7270 | 0.260 |
Why?
|
Cardiomyopathies | 1 | 2017 | 1911 | 0.260 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2019 | 10940 | 0.260 |
Why?
|
Inhalation Exposure | 3 | 2008 | 443 | 0.260 |
Why?
|
Evidence-Based Medicine | 2 | 2016 | 3608 | 0.250 |
Why?
|
Recovery of Function | 2 | 2014 | 2922 | 0.250 |
Why?
|
Predictive Value of Tests | 11 | 2017 | 15067 | 0.240 |
Why?
|
Coronary Angiography | 4 | 2021 | 4576 | 0.240 |
Why?
|
Patient Readmission | 1 | 2018 | 3117 | 0.240 |
Why?
|
Particle Size | 8 | 2005 | 1639 | 0.230 |
Why?
|
Injections | 6 | 2010 | 839 | 0.230 |
Why?
|
Refractory Period, Electrophysiological | 5 | 2010 | 39 | 0.230 |
Why?
|
Parasympathectomy | 1 | 2002 | 3 | 0.220 |
Why?
|
Acetylcholine | 4 | 2015 | 619 | 0.220 |
Why?
|
Ion Channels | 3 | 2013 | 1056 | 0.220 |
Why?
|
Guinea Pigs | 2 | 2014 | 1386 | 0.220 |
Why?
|
Disease Susceptibility | 7 | 2016 | 1781 | 0.210 |
Why?
|
Pacemaker, Artificial | 5 | 2010 | 815 | 0.210 |
Why?
|
Diagnosis, Computer-Assisted | 2 | 2008 | 717 | 0.210 |
Why?
|
Sinoatrial Node | 1 | 2002 | 101 | 0.210 |
Why?
|
Survival Rate | 7 | 2018 | 12786 | 0.210 |
Why?
|
Carbon Monoxide | 6 | 2005 | 531 | 0.210 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 3255 | 0.210 |
Why?
|
Aged | 31 | 2021 | 163178 | 0.210 |
Why?
|
Adult | 29 | 2023 | 213889 | 0.200 |
Why?
|
Random Allocation | 2 | 2018 | 2429 | 0.200 |
Why?
|
Reference Values | 4 | 2017 | 4974 | 0.200 |
Why?
|
Emergency Service, Hospital | 1 | 2021 | 7658 | 0.200 |
Why?
|
Cardiomyopathy, Hypertrophic | 2 | 2023 | 1265 | 0.200 |
Why?
|
Follow-Up Studies | 12 | 2023 | 39001 | 0.200 |
Why?
|
Tachycardia | 4 | 2000 | 619 | 0.180 |
Why?
|
Japan | 3 | 2018 | 1360 | 0.180 |
Why?
|
Signal Processing, Computer-Assisted | 2 | 2009 | 1524 | 0.180 |
Why?
|
Periodicity | 2 | 2002 | 364 | 0.180 |
Why?
|
Lung | 1 | 2018 | 9858 | 0.180 |
Why?
|
Insulin | 3 | 2013 | 6584 | 0.170 |
Why?
|
Nebulizers and Vaporizers | 1 | 2020 | 139 | 0.170 |
Why?
|
Drug Therapy, Combination | 4 | 2014 | 6487 | 0.170 |
Why?
|
Instillation, Drug | 1 | 2018 | 32 | 0.170 |
Why?
|
Blood Glucose | 1 | 2013 | 6259 | 0.170 |
Why?
|
Vascular Resistance | 8 | 2011 | 936 | 0.160 |
Why?
|
Reproducibility of Results | 5 | 2023 | 19894 | 0.160 |
Why?
|
Nerve Regeneration | 1 | 2004 | 788 | 0.160 |
Why?
|
Verapamil | 3 | 1996 | 244 | 0.160 |
Why?
|
Gadolinium DTPA | 1 | 2002 | 836 | 0.160 |
Why?
|
Paracentesis | 1 | 1998 | 95 | 0.160 |
Why?
|
Carbon | 5 | 2005 | 686 | 0.160 |
Why?
|
Muscle, Skeletal | 1 | 2013 | 4925 | 0.160 |
Why?
|
Purines | 1 | 2021 | 590 | 0.160 |
Why?
|
Incidence | 6 | 2020 | 20948 | 0.160 |
Why?
|
Dobutamine | 2 | 2011 | 123 | 0.160 |
Why?
|
Clonidine | 3 | 1989 | 164 | 0.150 |
Why?
|
Electrophysiology | 9 | 2005 | 1297 | 0.150 |
Why?
|
Cardiac Tamponade | 1 | 1998 | 173 | 0.150 |
Why?
|
Injections, Intravenous | 4 | 2014 | 1422 | 0.150 |
Why?
|
Electrodes | 3 | 2017 | 616 | 0.140 |
Why?
|
Hypertension, Pulmonary | 2 | 2012 | 1534 | 0.140 |
Why?
|
Ventricular Premature Complexes | 2 | 2016 | 111 | 0.140 |
Why?
|
Chronic Disease | 2 | 2023 | 9139 | 0.140 |
Why?
|
Monitoring, Ambulatory | 1 | 2019 | 358 | 0.140 |
Why?
|
Fentanyl | 2 | 1989 | 409 | 0.140 |
Why?
|
Enzyme Inhibitors | 3 | 2014 | 3794 | 0.140 |
Why?
|
Serotonin Antagonists | 1 | 1996 | 144 | 0.130 |
Why?
|
Telemetry | 1 | 2017 | 208 | 0.130 |
Why?
|
Specimen Handling | 1 | 2000 | 694 | 0.130 |
Why?
|
Myocardium | 5 | 2007 | 4775 | 0.130 |
Why?
|
Cardiotonic Agents | 2 | 2023 | 535 | 0.130 |
Why?
|
Pulse Therapy, Drug | 1 | 2014 | 35 | 0.130 |
Why?
|
Analysis of Variance | 2 | 2014 | 6356 | 0.130 |
Why?
|
Vasodilator Agents | 1 | 1999 | 974 | 0.120 |
Why?
|
Dreams | 1 | 1996 | 147 | 0.120 |
Why?
|
Stress, Physiological | 2 | 2000 | 1403 | 0.120 |
Why?
|
Vagotomy | 13 | 1995 | 83 | 0.120 |
Why?
|
Prazosin | 2 | 2011 | 96 | 0.120 |
Why?
|
Catheter Ablation | 2 | 2012 | 2758 | 0.120 |
Why?
|
Renal Dialysis | 3 | 2016 | 1783 | 0.120 |
Why?
|
Parasympathetic Nervous System | 8 | 2004 | 141 | 0.120 |
Why?
|
Tachycardia, Sinus | 1 | 1993 | 42 | 0.120 |
Why?
|
Trauma Centers | 1 | 1999 | 891 | 0.120 |
Why?
|
Cross-Over Studies | 2 | 2017 | 2029 | 0.110 |
Why?
|
Cyclic Nucleotide-Gated Cation Channels | 1 | 2013 | 39 | 0.110 |
Why?
|
Isoproterenol | 2 | 2013 | 399 | 0.110 |
Why?
|
Electroencephalography | 5 | 2022 | 6061 | 0.110 |
Why?
|
Biophysics | 1 | 2014 | 383 | 0.110 |
Why?
|
Child | 7 | 2019 | 77637 | 0.110 |
Why?
|
Particulate Matter | 4 | 2008 | 2529 | 0.110 |
Why?
|
Adaptation, Physiological | 2 | 2010 | 1311 | 0.110 |
Why?
|
Ischemia | 1 | 2022 | 1907 | 0.110 |
Why?
|
Pulmonary Artery | 1 | 2001 | 1911 | 0.110 |
Why?
|
Exercise | 4 | 2014 | 5611 | 0.110 |
Why?
|
Trachea | 1 | 2018 | 1076 | 0.110 |
Why?
|
Sensitivity and Specificity | 4 | 2016 | 14714 | 0.110 |
Why?
|
Operating Rooms | 1 | 1999 | 817 | 0.100 |
Why?
|
Natriuretic Agents | 1 | 2011 | 25 | 0.100 |
Why?
|
Adrenergic alpha-1 Receptor Agonists | 1 | 2011 | 19 | 0.100 |
Why?
|
Pressoreceptors | 5 | 2004 | 100 | 0.100 |
Why?
|
Causality | 2 | 2013 | 1275 | 0.100 |
Why?
|
Cats | 8 | 2000 | 986 | 0.100 |
Why?
|
Doxorubicin | 1 | 2018 | 2234 | 0.100 |
Why?
|
Ultrasonography, Interventional | 2 | 1999 | 1486 | 0.100 |
Why?
|
Cardiac Complexes, Premature | 13 | 2004 | 64 | 0.100 |
Why?
|
Patient Selection | 2 | 2016 | 4210 | 0.100 |
Why?
|
Pyrazoles | 1 | 2021 | 1970 | 0.100 |
Why?
|
Anesthesia, General | 1 | 2018 | 1171 | 0.100 |
Why?
|
Health Surveys | 3 | 2018 | 4036 | 0.100 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2011 | 169 | 0.090 |
Why?
|
Gene Transfer Techniques | 2 | 2013 | 1224 | 0.090 |
Why?
|
Artifacts | 1 | 2019 | 1904 | 0.090 |
Why?
|
Adipose Tissue | 1 | 2002 | 3280 | 0.090 |
Why?
|
Drug Monitoring | 1 | 2016 | 953 | 0.090 |
Why?
|
Carbazoles | 1 | 2012 | 226 | 0.090 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2014 | 11729 | 0.090 |
Why?
|
Vehicle Emissions | 2 | 2005 | 665 | 0.090 |
Why?
|
Algorithms | 5 | 2008 | 13869 | 0.090 |
Why?
|
Sulfur Dioxide | 3 | 2005 | 177 | 0.090 |
Why?
|
Luminescent Agents | 1 | 2010 | 54 | 0.090 |
Why?
|
Fluoroscopy | 1 | 2014 | 924 | 0.090 |
Why?
|
Models, Animal | 3 | 2012 | 2172 | 0.090 |
Why?
|
Cicatrix | 1 | 2016 | 763 | 0.090 |
Why?
|
Disasters | 1 | 1996 | 511 | 0.090 |
Why?
|
Adenoviridae | 2 | 2012 | 1100 | 0.090 |
Why?
|
Silicones | 2 | 2007 | 250 | 0.090 |
Why?
|
Placebos | 1 | 2014 | 1674 | 0.090 |
Why?
|
Aspirin | 1 | 2001 | 3283 | 0.090 |
Why?
|
Monitoring, Physiologic | 2 | 2014 | 1738 | 0.090 |
Why?
|
Receptors, Opioid | 1 | 1989 | 155 | 0.090 |
Why?
|
Behavior | 1 | 1992 | 559 | 0.090 |
Why?
|
Risk | 3 | 2018 | 9677 | 0.080 |
Why?
|
Constriction | 5 | 1993 | 181 | 0.080 |
Why?
|
Young Adult | 5 | 2019 | 56392 | 0.080 |
Why?
|
Aortic Valve Stenosis | 1 | 2021 | 1955 | 0.080 |
Why?
|
Femoral Artery | 3 | 2011 | 845 | 0.080 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2012 | 1574 | 0.080 |
Why?
|
Cause of Death | 3 | 2018 | 3580 | 0.080 |
Why?
|
Magnesium | 1 | 2012 | 813 | 0.080 |
Why?
|
Regional Blood Flow | 2 | 2011 | 1525 | 0.080 |
Why?
|
Contrast Media | 1 | 2002 | 5301 | 0.080 |
Why?
|
Adolescent | 5 | 2019 | 85729 | 0.080 |
Why?
|
Muscle Proteins | 2 | 2013 | 1158 | 0.080 |
Why?
|
Heart Failure, Systolic | 1 | 2009 | 126 | 0.080 |
Why?
|
Sodium | 2 | 2012 | 1622 | 0.080 |
Why?
|
Nitrogen Dioxide | 3 | 2005 | 490 | 0.080 |
Why?
|
Prevalence | 4 | 2016 | 15211 | 0.070 |
Why?
|
Glycopyrrolate | 2 | 1998 | 33 | 0.070 |
Why?
|
Aged, 80 and over | 11 | 2021 | 57744 | 0.070 |
Why?
|
Sex Factors | 1 | 2021 | 10394 | 0.070 |
Why?
|
Hippocampus | 1 | 1999 | 3672 | 0.070 |
Why?
|
Postoperative Complications | 3 | 2021 | 15281 | 0.070 |
Why?
|
Cardiac Output, Low | 1 | 2007 | 195 | 0.070 |
Why?
|
Cardiac Glycosides | 1 | 1986 | 30 | 0.070 |
Why?
|
Ganglia | 1 | 2006 | 88 | 0.070 |
Why?
|
Severity of Illness Index | 2 | 2017 | 15526 | 0.070 |
Why?
|
Comorbidity | 2 | 2013 | 10380 | 0.070 |
Why?
|
Naloxone | 1 | 1989 | 365 | 0.070 |
Why?
|
Muscarinic Antagonists | 2 | 1998 | 137 | 0.070 |
Why?
|
Receptors, Muscarinic | 4 | 1995 | 156 | 0.070 |
Why?
|
Equipment Design | 2 | 2007 | 3574 | 0.070 |
Why?
|
Child, Preschool | 2 | 2019 | 40964 | 0.070 |
Why?
|
Intensive Care Units | 1 | 1999 | 3679 | 0.070 |
Why?
|
Prospective Studies | 5 | 2019 | 53250 | 0.070 |
Why?
|
Morphine | 3 | 1986 | 657 | 0.070 |
Why?
|
Case-Control Studies | 2 | 2021 | 21733 | 0.060 |
Why?
|
Infusion Pumps, Implantable | 1 | 2005 | 156 | 0.060 |
Why?
|
Atherosclerosis | 1 | 2021 | 3445 | 0.060 |
Why?
|
Angioplasty, Balloon, Coronary | 3 | 2009 | 1874 | 0.060 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2010 | 858 | 0.060 |
Why?
|
Sudden Infant Death | 1 | 1988 | 291 | 0.060 |
Why?
|
Green Fluorescent Proteins | 1 | 2010 | 2086 | 0.060 |
Why?
|
Sulfates | 2 | 2005 | 390 | 0.060 |
Why?
|
Drug Design | 1 | 2010 | 1075 | 0.060 |
Why?
|
GAP-43 Protein | 1 | 2004 | 152 | 0.060 |
Why?
|
Kinetics | 3 | 2013 | 6476 | 0.060 |
Why?
|
Multicenter Studies as Topic | 1 | 2009 | 1676 | 0.060 |
Why?
|
Automobile Driving | 1 | 2009 | 430 | 0.060 |
Why?
|
Norepinephrine | 11 | 1987 | 909 | 0.060 |
Why?
|
Air Pollutants, Occupational | 1 | 2006 | 407 | 0.060 |
Why?
|
Heart Block | 1 | 2005 | 410 | 0.060 |
Why?
|
Control Groups | 1 | 2004 | 105 | 0.060 |
Why?
|
Societies, Medical | 2 | 2017 | 3740 | 0.060 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2011 | 1572 | 0.060 |
Why?
|
Hospitalization | 2 | 2022 | 10259 | 0.060 |
Why?
|
Environmental Exposure | 5 | 2005 | 4232 | 0.060 |
Why?
|
Respiration | 2 | 2000 | 1653 | 0.060 |
Why?
|
Double-Blind Method | 1 | 2017 | 12020 | 0.060 |
Why?
|
Nitric Oxide Donors | 1 | 2003 | 121 | 0.060 |
Why?
|
Potassium | 7 | 1987 | 1336 | 0.050 |
Why?
|
Aorta | 3 | 2006 | 2062 | 0.050 |
Why?
|
Drug Administration Schedule | 1 | 2010 | 4931 | 0.050 |
Why?
|
Mesenteric Arteries | 3 | 1971 | 183 | 0.050 |
Why?
|
Adrenal Glands | 5 | 1975 | 547 | 0.050 |
Why?
|
Buprenorphine | 1 | 1989 | 640 | 0.050 |
Why?
|
Neural Pathways | 1 | 2013 | 2971 | 0.050 |
Why?
|
Quality of Life | 1 | 2023 | 12788 | 0.050 |
Why?
|
Positron-Emission Tomography | 1 | 2017 | 6237 | 0.050 |
Why?
|
Acceleration | 1 | 2022 | 183 | 0.050 |
Why?
|
Atropine | 7 | 1988 | 244 | 0.050 |
Why?
|
Myocardial Reperfusion | 2 | 2011 | 351 | 0.050 |
Why?
|
Ozone | 2 | 2005 | 469 | 0.050 |
Why?
|
Infant | 3 | 2019 | 35122 | 0.050 |
Why?
|
Receptors, Adrenergic | 4 | 1986 | 155 | 0.050 |
Why?
|
Models, Biological | 5 | 2008 | 9582 | 0.050 |
Why?
|
Heart Septum | 1 | 2002 | 312 | 0.050 |
Why?
|
Age Factors | 1 | 2017 | 18355 | 0.050 |
Why?
|
Diuretics | 1 | 2023 | 591 | 0.050 |
Why?
|
Ergometry | 2 | 2010 | 17 | 0.050 |
Why?
|
Neural Conduction | 2 | 1978 | 441 | 0.040 |
Why?
|
Psychophysiology | 1 | 2000 | 135 | 0.040 |
Why?
|
Review Literature as Topic | 1 | 2001 | 336 | 0.040 |
Why?
|
Cohort Studies | 3 | 2019 | 40545 | 0.040 |
Why?
|
Proportional Hazards Models | 5 | 2014 | 12354 | 0.040 |
Why?
|
Heart Function Tests | 3 | 1996 | 328 | 0.040 |
Why?
|
Equipment Safety | 1 | 2000 | 263 | 0.040 |
Why?
|
Multivariate Analysis | 4 | 2010 | 12243 | 0.040 |
Why?
|
Ultrasonography | 1 | 2012 | 5986 | 0.040 |
Why?
|
Punctures | 1 | 2000 | 374 | 0.040 |
Why?
|
Disease-Free Survival | 1 | 2009 | 6895 | 0.040 |
Why?
|
Platelet Aggregation | 4 | 1986 | 798 | 0.040 |
Why?
|
Kidney Failure, Chronic | 1 | 2010 | 2534 | 0.040 |
Why?
|
Atenolol | 1 | 1998 | 100 | 0.040 |
Why?
|
Tissue Distribution | 1 | 2002 | 2327 | 0.040 |
Why?
|
Hemorrhage | 3 | 2000 | 3458 | 0.040 |
Why?
|
Feasibility Studies | 1 | 2007 | 5078 | 0.040 |
Why?
|
Membranes | 1 | 1997 | 173 | 0.040 |
Why?
|
Nifedipine | 2 | 1988 | 227 | 0.040 |
Why?
|
Vasomotor System | 2 | 1985 | 209 | 0.040 |
Why?
|
Laparotomy | 1 | 1999 | 473 | 0.040 |
Why?
|
Europe | 1 | 2003 | 3336 | 0.040 |
Why?
|
Disease Progression | 2 | 2011 | 13273 | 0.030 |
Why?
|
Gastrostomy | 1 | 1999 | 310 | 0.030 |
Why?
|
Occupational Exposure | 1 | 2006 | 1787 | 0.030 |
Why?
|
Atrial Appendage | 1 | 2000 | 282 | 0.030 |
Why?
|
Precipitating Factors | 1 | 1996 | 52 | 0.030 |
Why?
|
Nervous System | 2 | 1977 | 554 | 0.030 |
Why?
|
Ions | 1 | 1997 | 265 | 0.030 |
Why?
|
Muscle Contraction | 2 | 1971 | 1233 | 0.030 |
Why?
|
Serotonin | 3 | 1987 | 1017 | 0.030 |
Why?
|
Acute Disease | 3 | 2004 | 7150 | 0.030 |
Why?
|
Tracheostomy | 1 | 1999 | 401 | 0.030 |
Why?
|
Tobacco Smoke Pollution | 1 | 2001 | 816 | 0.030 |
Why?
|
Wakefulness | 2 | 1995 | 1243 | 0.030 |
Why?
|
Angina Pectoris, Variant | 1 | 1994 | 55 | 0.030 |
Why?
|
Receptors, Adrenergic, alpha | 2 | 1985 | 149 | 0.030 |
Why?
|
Cardiovascular System | 2 | 1992 | 828 | 0.030 |
Why?
|
Retrospective Studies | 7 | 2021 | 77410 | 0.030 |
Why?
|
Affect | 1 | 2021 | 1473 | 0.030 |
Why?
|
Fear | 2 | 1992 | 1438 | 0.030 |
Why?
|
Microcomputers | 1 | 1993 | 147 | 0.030 |
Why?
|
Hypothalamus | 2 | 1976 | 1061 | 0.030 |
Why?
|
Forecasting | 1 | 2002 | 2950 | 0.030 |
Why?
|
Lymphocytes | 1 | 2000 | 2615 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2009 | 9944 | 0.030 |
Why?
|
Adrenalectomy | 6 | 1975 | 342 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 2008 | 7908 | 0.030 |
Why?
|
Biological Transport | 1 | 1997 | 2119 | 0.030 |
Why?
|
Fourier Analysis | 1 | 1993 | 446 | 0.030 |
Why?
|
Potassium Channel Blockers | 1 | 2012 | 171 | 0.030 |
Why?
|
Perfusion | 4 | 1986 | 1359 | 0.030 |
Why?
|
Psychotherapy | 1 | 2021 | 1640 | 0.030 |
Why?
|
Phenylephrine | 4 | 1983 | 301 | 0.020 |
Why?
|
Linear Models | 2 | 2014 | 5952 | 0.020 |
Why?
|
Denervation | 6 | 1983 | 278 | 0.020 |
Why?
|
Internationality | 1 | 2017 | 1002 | 0.020 |
Why?
|
Angioplasty | 1 | 1994 | 364 | 0.020 |
Why?
|
Adrenal Insufficiency | 2 | 1970 | 184 | 0.020 |
Why?
|
Polysomnography | 2 | 2000 | 1776 | 0.020 |
Why?
|
Ventricular Function | 3 | 1978 | 415 | 0.020 |
Why?
|
Image Enhancement | 1 | 2002 | 2915 | 0.020 |
Why?
|
Posture | 1 | 1995 | 957 | 0.020 |
Why?
|
Physical Conditioning, Animal | 1 | 1994 | 354 | 0.020 |
Why?
|
Atropine Derivatives | 2 | 1988 | 5 | 0.020 |
Why?
|
Reperfusion | 1 | 1991 | 283 | 0.020 |
Why?
|
Ganglionectomy | 1 | 1989 | 12 | 0.020 |
Why?
|
Mathematics | 1 | 1991 | 727 | 0.020 |
Why?
|
Lung Diseases | 1 | 2000 | 1887 | 0.020 |
Why?
|
Synaptic Transmission | 2 | 1987 | 1176 | 0.020 |
Why?
|
Reoperation | 1 | 1999 | 4200 | 0.020 |
Why?
|
Behavior, Animal | 2 | 1987 | 1880 | 0.020 |
Why?
|
Propranolol | 7 | 1983 | 502 | 0.020 |
Why?
|
Echocardiography | 1 | 2021 | 5096 | 0.020 |
Why?
|
Environmental Monitoring | 2 | 2005 | 1413 | 0.020 |
Why?
|
Coloring Agents | 1 | 1971 | 565 | 0.020 |
Why?
|
Peripheral Nerves | 2 | 1984 | 466 | 0.020 |
Why?
|
Receptors, Opioid, mu | 1 | 1989 | 182 | 0.020 |
Why?
|
Ganglia, Sympathetic | 1 | 1988 | 62 | 0.020 |
Why?
|
Computer Simulation | 1 | 2002 | 6188 | 0.020 |
Why?
|
Blood Volume | 1 | 1969 | 565 | 0.020 |
Why?
|
Central Nervous System | 2 | 1987 | 1358 | 0.020 |
Why?
|
Phenelzine | 1 | 1987 | 28 | 0.020 |
Why?
|
Neutrophils | 1 | 2000 | 3718 | 0.020 |
Why?
|
Blood Vessels | 2 | 1971 | 1124 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2014 | 3503 | 0.020 |
Why?
|
5-Hydroxytryptophan | 1 | 1987 | 32 | 0.020 |
Why?
|
Parasympatholytics | 1 | 1988 | 91 | 0.020 |
Why?
|
Carbidopa | 1 | 1987 | 31 | 0.020 |
Why?
|
Shock | 1 | 1970 | 318 | 0.020 |
Why?
|
Bicycling | 1 | 2009 | 176 | 0.020 |
Why?
|
Consensus | 1 | 2017 | 2954 | 0.020 |
Why?
|
Diet, Atherogenic | 1 | 1987 | 96 | 0.020 |
Why?
|
Consciousness | 3 | 1990 | 571 | 0.020 |
Why?
|
Epoprostenol | 3 | 1983 | 254 | 0.020 |
Why?
|
Hypokalemia | 2 | 1986 | 153 | 0.020 |
Why?
|
Desoxycorticosterone | 1 | 1966 | 50 | 0.020 |
Why?
|
Cholesterol, Dietary | 1 | 1987 | 231 | 0.020 |
Why?
|
Muscle, Smooth | 1 | 1971 | 934 | 0.020 |
Why?
|
Muscles | 1 | 1971 | 1613 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 1999 | 5388 | 0.020 |
Why?
|
Welding | 1 | 2006 | 89 | 0.020 |
Why?
|
Critical Illness | 1 | 1999 | 2670 | 0.020 |
Why?
|
ROC Curve | 1 | 2013 | 3527 | 0.020 |
Why?
|
Microspheres | 1 | 2008 | 777 | 0.020 |
Why?
|
Adrenergic beta-Agonists | 1 | 1987 | 346 | 0.020 |
Why?
|
Odds Ratio | 2 | 2013 | 9848 | 0.020 |
Why?
|
Vascular Patency | 1 | 1988 | 887 | 0.020 |
Why?
|
Propylamines | 1 | 1986 | 165 | 0.020 |
Why?
|
Vasoconstriction | 1 | 1988 | 597 | 0.020 |
Why?
|
Logistic Models | 2 | 2013 | 13404 | 0.020 |
Why?
|
Research | 1 | 1993 | 1999 | 0.020 |
Why?
|
Thoracotomy | 1 | 2006 | 363 | 0.020 |
Why?
|
Angina, Unstable | 1 | 2009 | 926 | 0.020 |
Why?
|
Adrenergic alpha-Antagonists | 1 | 1985 | 174 | 0.020 |
Why?
|
United States | 2 | 2003 | 69859 | 0.020 |
Why?
|
Coronary Artery Bypass | 1 | 1994 | 2288 | 0.020 |
Why?
|
Conditioning, Classical | 1 | 1987 | 366 | 0.020 |
Why?
|
Health Status Indicators | 1 | 2010 | 970 | 0.020 |
Why?
|
Nucleotides, Cyclic | 1 | 1985 | 81 | 0.020 |
Why?
|
Receptors, Adrenergic, beta | 1 | 1985 | 246 | 0.010 |
Why?
|
Methoxamine | 1 | 1983 | 45 | 0.010 |
Why?
|
Angiotensin II | 1 | 1966 | 880 | 0.010 |
Why?
|
Cerebrovascular Circulation | 1 | 1993 | 2732 | 0.010 |
Why?
|
Sulfinpyrazone | 1 | 1982 | 14 | 0.010 |
Why?
|
Reflex | 1 | 1985 | 365 | 0.010 |
Why?
|
Brain Chemistry | 1 | 1986 | 982 | 0.010 |
Why?
|
Dust | 1 | 2005 | 478 | 0.010 |
Why?
|
Neurotransmitter Agents | 1 | 1986 | 646 | 0.010 |
Why?
|
Air Pollution, Indoor | 1 | 2009 | 857 | 0.010 |
Why?
|
Social Environment | 1 | 1987 | 1022 | 0.010 |
Why?
|
Carotid Sinus | 3 | 1979 | 45 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 2 | 2004 | 8300 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 2016 | 35409 | 0.010 |
Why?
|
Rats | 4 | 2004 | 24250 | 0.010 |
Why?
|
Adrenal Cortex Hormones | 1 | 1970 | 1854 | 0.010 |
Why?
|
Sympathomimetics | 1 | 1981 | 57 | 0.010 |
Why?
|
Muscle Tonus | 2 | 1971 | 81 | 0.010 |
Why?
|
Prostaglandins | 1 | 1982 | 405 | 0.010 |
Why?
|
Signal Transduction | 1 | 2004 | 23398 | 0.010 |
Why?
|
Bronchoalveolar Lavage | 1 | 2000 | 120 | 0.010 |
Why?
|
Electrooculography | 1 | 2000 | 116 | 0.010 |
Why?
|
Dexamethasone | 2 | 1968 | 1950 | 0.010 |
Why?
|
Regression Analysis | 1 | 2010 | 6457 | 0.010 |
Why?
|
Shock, Surgical | 2 | 1970 | 10 | 0.010 |
Why?
|
Mass Screening | 1 | 2016 | 5251 | 0.010 |
Why?
|
Postoperative Care | 1 | 2006 | 1485 | 0.010 |
Why?
|
Digitalis Glycosides | 1 | 1979 | 47 | 0.010 |
Why?
|
Reserpine | 2 | 1981 | 66 | 0.010 |
Why?
|
Prenylamine | 1 | 1979 | 1 | 0.010 |
Why?
|
Utah | 1 | 1999 | 126 | 0.010 |
Why?
|
Massachusetts | 2 | 2005 | 8660 | 0.010 |
Why?
|
Bronchitis | 1 | 2000 | 200 | 0.010 |
Why?
|
Cell Membrane Permeability | 2 | 1971 | 589 | 0.010 |
Why?
|
Software | 1 | 1993 | 4440 | 0.010 |
Why?
|
Databases, Factual | 1 | 2013 | 7729 | 0.010 |
Why?
|
Glucose | 2 | 1981 | 4398 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2018 | 25032 | 0.010 |
Why?
|
Brain | 3 | 2000 | 26345 | 0.010 |
Why?
|
Electromyography | 1 | 2000 | 1378 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2010 | 12954 | 0.010 |
Why?
|
Pulse | 1 | 1974 | 228 | 0.010 |
Why?
|
Immunity, Cellular | 1 | 2000 | 1608 | 0.010 |
Why?
|
Calcium Chloride | 2 | 1971 | 77 | 0.010 |
Why?
|
Seasons | 1 | 1999 | 1493 | 0.010 |
Why?
|
Cardiology | 1 | 1984 | 1668 | 0.010 |
Why?
|
Blood Circulation | 2 | 1969 | 251 | 0.010 |
Why?
|
Potassium Chloride | 1 | 1971 | 237 | 0.010 |
Why?
|
Serum Albumin, Radio-Iodinated | 1 | 1969 | 37 | 0.010 |
Why?
|
Rheology | 1 | 1971 | 345 | 0.010 |
Why?
|
Practolol | 2 | 1982 | 3 | 0.010 |
Why?
|
Venoms | 1 | 1970 | 90 | 0.010 |
Why?
|
Homeostasis | 1 | 2000 | 3337 | 0.010 |
Why?
|
Shock, Hemorrhagic | 1 | 1970 | 220 | 0.010 |
Why?
|
Infusions, Parenteral | 2 | 1979 | 419 | 0.010 |
Why?
|
Blood | 1 | 1971 | 596 | 0.000 |
Why?
|
Hematocrit | 1 | 1969 | 636 | 0.000 |
Why?
|
Cardiac Output | 2 | 1968 | 854 | 0.000 |
Why?
|
3,4-Dihydroxyphenylacetic Acid | 1 | 1987 | 64 | 0.000 |
Why?
|
Methoxyhydroxyphenylglycol | 1 | 1987 | 93 | 0.000 |
Why?
|
Hydroxyindoleacetic Acid | 1 | 1987 | 90 | 0.000 |
Why?
|
Pressure | 1 | 1971 | 1205 | 0.000 |
Why?
|
Aorta, Thoracic | 1 | 1974 | 1084 | 0.000 |
Why?
|
Infant, Newborn | 1 | 1988 | 25609 | 0.000 |
Why?
|
Hindlimb | 1 | 1969 | 503 | 0.000 |
Why?
|
Methacholine Compounds | 1 | 1986 | 35 | 0.000 |
Why?
|
Stimulation, Chemical | 2 | 1978 | 326 | 0.000 |
Why?
|
Methacholine Chloride | 1 | 1986 | 233 | 0.000 |
Why?
|
Lidocaine | 2 | 1982 | 544 | 0.000 |
Why?
|
Albuterol | 1 | 1987 | 208 | 0.000 |
Why?
|
Caffeine | 1 | 1971 | 699 | 0.000 |
Why?
|
Adenosine Triphosphate | 1 | 1971 | 2029 | 0.000 |
Why?
|
Temperature | 1 | 1971 | 2202 | 0.000 |
Why?
|
Oxprenolol | 1 | 1983 | 1 | 0.000 |
Why?
|
Pindolol | 1 | 1983 | 32 | 0.000 |
Why?
|
Shock, Septic | 1 | 1970 | 775 | 0.000 |
Why?
|
Prostaglandins E | 1 | 1983 | 172 | 0.000 |
Why?
|
Alprostadil | 1 | 1983 | 89 | 0.000 |
Why?
|
Ergonovine | 1 | 1982 | 15 | 0.000 |
Why?
|
Indomethacin | 1 | 1983 | 332 | 0.000 |
Why?
|
Drug Synergism | 1 | 1966 | 1794 | 0.000 |
Why?
|
Systole | 1 | 1983 | 958 | 0.000 |
Why?
|
Adrenergic Fibers | 1 | 1980 | 21 | 0.000 |
Why?
|
Solutions | 1 | 1981 | 426 | 0.000 |
Why?
|
Strophanthidin | 1 | 1979 | 15 | 0.000 |
Why?
|
Blood Flow Velocity | 1 | 1983 | 1423 | 0.000 |
Why?
|
Ouabain | 1 | 1979 | 264 | 0.000 |
Why?
|
Protein Binding | 1 | 1971 | 9377 | 0.000 |
Why?
|
Methods | 1 | 1979 | 1128 | 0.000 |
Why?
|
Electrolytes | 1 | 1979 | 282 | 0.000 |
Why?
|
Arterial Occlusive Diseases | 1 | 1983 | 793 | 0.000 |
Why?
|
Cisterna Magna | 1 | 1978 | 41 | 0.000 |
Why?
|
Sympathectomy | 1 | 1977 | 89 | 0.000 |
Why?
|
Phentolamine | 1 | 1976 | 104 | 0.000 |
Why?
|
Physical Stimulation | 1 | 1978 | 525 | 0.000 |
Why?
|
Parasympathomimetics | 1 | 1976 | 26 | 0.000 |
Why?
|
Ligation | 1 | 1977 | 452 | 0.000 |
Why?
|
Evaluation Studies as Topic | 1 | 1978 | 1677 | 0.000 |
Why?
|
Electroshock | 1 | 1973 | 122 | 0.000 |
Why?
|
Oxygen | 1 | 1983 | 4189 | 0.000 |
Why?
|
Buffers | 1 | 1971 | 147 | 0.000 |
Why?
|
Mineralocorticoids | 1 | 1968 | 38 | 0.000 |
Why?
|
Transducers | 1 | 1968 | 253 | 0.000 |
Why?
|
Dextrans | 1 | 1968 | 595 | 0.000 |
Why?
|
Aldosterone | 1 | 1968 | 877 | 0.000 |
Why?
|
Hypotension | 1 | 1968 | 884 | 0.000 |
Why?
|
Hydrocortisone | 1 | 1968 | 1826 | 0.000 |
Why?
|
Glucocorticoids | 1 | 1968 | 2107 | 0.000 |
Why?
|